Medtronic to acquire wearable insulin patch maker EOFlow

Go back to Medtronic to acquire wearable insulin patch maker EOFlow

Medtronic, Inc. (MDT) PT Raised to $100 at Evercore ISI, 'we find MDT compelling in a choppy macro environment'

May 25, 2023 11:15 AM EDT

Evercore ISI analyst Vijay Kumar raised the price target on Medtronic, Inc. (NYSE: MDT) to $100.00 (from $88.00) while maintaining a Outperform rating.

The analyst comments "Generally, inlinish results (vs expecs) and Guide are not reasons to be cheeringbut given the uniqueness of MDT situation, we see the 4Q print as a clearing event and time for investors to get incrementally constructive. For background, MDT has had a tough 18 months, starting with the late 2021 triple whammy of Diabetes warning letter, RDN headline miss and pushout of robotics. This... More

Deutsche Bank Keeps Hold Rating on Medtronic, Inc. (MDT), 'Good, but maybe not quite good enough'

May 25, 2023 11:13 AM EDT

Deutsche Bank analyst Pito Chickering reiterated a Hold rating and $87.00 price target on Medtronic, Inc. (NYSE: MDT).

The analyst comments "Net-net. The debate heading into the quarter was simple: (1) What does 4Q results imply about guidance; (2) Is FY 2024 guidance a... More